Bluefin Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bluefin Capital Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,000	Closed	-$213K	–	173
2024 Q1	$213K	Buy	+10,000	New	+$120K	0.03%	88

Bluefin Capital Management's FUSN Position: Q2 2024 in Review

Bluefin Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 10,000 shares — an estimated $213K sold.

Bluefin Capital Management first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $213K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Bluefin Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Bluefin Capital Management sold 10,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $213K.
Bluefin Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Bluefin Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $213K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Bluefin Capital Management's 13F filing for Q2 2024, filed 10 Sep 2024.